Sogroya (somapacitan)
pCPA File Number:
22502
Negotiation Status:
Under consideration for negotiation
Indication(s):
Growth hormone deficiency
Sponsor/Manufacturer:
Novo Nordisk Canada Inc.
CDA-AMC Project Number:
SR0779-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable